Syphilis Mixed Titer Panel

Syphilis Mixed Titer Performance Panel


A newly developed immunochromatography assay, DainaScreen TPAb (Dainabot, Tokyo), to detect antibodies specific to Treponema pallidum was evaluated. As soon as we examined serum and plasma samples of Syphilis Blended Titer Effectivity Panel PSS201 (Boston Biomedica, Inc. , Bridgewater, MA, U.S.A.), the entire test outcomes obtained by DainaScreen TPAb have been akin to those determined by fluorescent treponemal antibody absorption test (FTA-ABS).

Every within-run and day-to-day variation checks have been extraordinarily precise, and no discrepant interpretation was obtained by the fully completely different medical technicians carried out. Moreover, the testings of total blood and plasma for specific particular person samples gave related interpretations. The minimal detectable antibody titer was equal to that of Mediace TPLA (Sekisui Chemical substances, Osaka) determined by Behring Nephelometer Analyzer (Dade Behring, Marburg, Germany). The entire test outcomes by DainaScreen TPAb for medical serum samples have been akin to those by Mediace TPLA. With these outcomes, we’re capable of conclude that DainaScreen TPAb is a quick, smart and easy-to-perform completely different to detect antibodies specific to Treponema pallidum, notably as being a point-of-care testing.

Assays carried out using industrial kits as indicated. Outcomes have been provided by the panel supplier. RPR, quick plasma reagin; ATA, anti-Treponema antibody; S/Co, signal to cutoff ratio; EIA, enzyme immunoassay; TPPA, Treponema pallidum particle agglutination assay; TPHA, Treponema pallidum haemagglutination assay; Neg, antagonistic; R, reactive; NR, non-reactive. RPR outcomes are endpoint dilutions. S/Co ratios ≥1.Zero are thought-about reactive.

b Values level out S/Co ratios obtained on this analysis, using the in-house TRF immunoassays with 10 min and 1 h incubation events. Samples with S/Co values <1.Zero are designated as antagonistic (−) and other people with values ≥1.Zero are designated as optimistic (+).




Using Brazilian Ministry of Properly being info on women acknowledged with maternal syphilis between January 1, 2010, and December 31, 2018, we carried out a random-effects logistic regression model with a cluster correction on the state diploma to guage predictive elements of penicillin treatment.



We observed yearly will enhance in cases of pregnant women with syphilis from 2010 to 2018. There was important variation by state: 52,451 cases have been reported in São Paulo, adopted by 26,838 in Rio de Janeiro. Amongst 215,937 cases of maternal syphilis, 91·3% obtained penicillin. Throughout the random-effects model, a non-treponemal titer ≥1:16 was associated to 1·44 bigger odds of receiving penicillin (95% confidence interval [CI]: 1·391·48), and prenatal care was associated to a 2·12 elevated odds of receiving penicillin (95% CI: 2·022·21). Although there could also be an affiliation between the absence of prenatal care and inadequate treatment for syphilis, 83·2% of ladies on this cohort who did not get hold of penicillin have been engaged in prenatal care.


Suppliers might inappropriately exclude low non-treponemal titers and thereby fail to utilize penicillin treatment in maternal syphilis. Whereas the explanation for the maternal syphilis epidemic in Brazil is multifactorial, we take into account our findings could be utilized to develop centered interventions all by way of Brazil along with type public nicely being initiatives globally.



  • Characterised samples and full info are provided for comparative analysis.
  • No preservatives have been added
  • 1 vial per member, 17 members, 0.5mL per vial


Mixed Titer Bacteria Panel for Platelets (12 Samples 0.1 mL)

820000 12 Samples 0.1 mL
EUR 465

SeroDetect HCV-Ab Mixed Titer Verification Panel I (15 X 0.25 mL)

KZMC022 15 X 0.25 mL
EUR 269

Performance Check Solution

531-PCS 1ML
EUR 120

Performance Check Standard

507-PC 1ML
EUR 224.4

Performance Check Solution

5081-PC 1ML
EUR 51.6

Performance Check Solution

5252-PCS 1ML
EUR 52.8

Cap GL25 High Performance

BOT2107 PK5
EUR 45.6

Ni Sepharose High Performance 100mL

17526802 EACH
EUR 1760.4

Syphilis anti-TP syphilis ELISA test

99 96T/Box Ask for price
Description: ELISA based test for quantitative detection of Syphilis anti-TP syphilis

High Performance ELISA Buffer

85R-105 55 ml
EUR 379.2
Description: High Performance ELISA Buffer for high sensitivity ELISA assays

IMAC Sepharose High Performance 100mL

17092007 EACH
EUR 1645.2

Butyl Sepharose High Performance 200mL

17543202 EACH
EUR 921.6

Duran Cap GL45 High Performance

BOT2104 PK5
EUR 93.6

Dextrin Sepharose High Performance 100mL

28935597 EACH
EUR 1125.6

Dextrin Sepharose High Performance 100mL

28935598 EACH
EUR 3626.4

Ni Sepharose High Performance 25mL

17526801 EACH
EUR 517.2

Glutathione Sepharose High Performance 100mL

17527902 EACH
EUR 3156

Duran Pouring Ring High Performance

BOT2106 PK5
EUR 22.8

Q Sepharose High Performance 75 mL

17101401 EACH
EUR 469.2

Laboratory Performance Check Standard

5511-PC 1ML
EUR 120

Laboratory Performance Check Standard

LPC-1-100N 125ML
EUR 472.8

Laboratory Performance Check Standard

LPC-1-500N 500ML
EUR 793.2

Phenyl Sepharose High Performance 75mL

17108201 EACH
EUR 502.8

Streptavidin Sepharose High Performance 5mL

17511301 EACH
EUR 670.8

StrepTactin Sepharose High Performance 10mL

28935599 EACH
EUR 888

StrepTactin Sepharose High Performance 10mL

28935600 EACH
EUR 3956.4

Stuart SS20 High Performance Overhead Stirrer

EUR 1477.2

Syphilis TpN17 Protein

abx169035-1mg 1 mg
EUR 526.8

Leave a Comment

Your email address will not be published.